Inmune Stock News

INmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call Transcript

Company to host conference call today, May 5, at 4:30pm ET Company to host conference call today, May 5, at 4:30pm ET

Management to host conference call at 4:30 pm ET on that day Management to host conference call at 4:30 pm ET on that day

Based on the theory that chronic low-grade inflammation is behind many ailments, the company's therapies are setting out to enlist the innate immune system to combat these.

The stock price of INmune Bio Inc (NASDAQ: INMB) increased by over 3% pre-market. This is why it happened.

INmune Bio, Inc. (INMB) CEO RJ Tesi on Q4 2020 Results - Earnings Call Transcript

Company to host conference call today, March 4, at 4:30pm ET Company to host conference call today, March 4, at 4:30pm ET

The wild ride for the biotech stock started with its announcement of results from a phase 1b study.

Interim data show CSF biomarkers of neurodegeneration and synaptic dysfunction as well as neuroimaging biomarkers improved after three months of therapy with XPro1595

Webinar to review expanded biomarker data from the company's Phase 1b clinical trial of XPro1595 targeting neuroinflammation in patients with Alzheimer's disease

Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great stock picking abilitie

In this article we present the list of Top 10 Stocks Billionaire George Soros Just Bought. Click to skip ahead and see the  Top 5 Stocks Billionaire George Soros Just Bought .

LA JOLLA, Calif, Nov. 09, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the, “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient's

INmune Bio, Inc. (INMB) CEO RJ Tesi on Q3 2020 Results - Earnings Call Transcript

Management to host conference call at 4:30 pm ET on that day